T-Mobile Us, Inc.
$276.05B- Market cap
- $190.23B
- Debt
- +$91.42B
- Cash
- −$5.60B
Capital structure 68% equity / 32% debt · EV / Revenue 3.13x · EV proxy / EBITDA proxy 8.68x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TMUS stock price vs CHTR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CHTR's multiple
Needs CHTR P/E.
Implied fair value · at TMUS's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 68% equity / 32% debt · EV / Revenue 3.13x · EV proxy / EBITDA proxy 8.68x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
T-MOBILE US, INC. · implied price per share
Bear
$75.82
Base
$105.53
Bull
$145.63
Charter Communications, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TMUS can sustain its 8.5% revenue growth and 24.2% ROIC while keeping leverage near 0.5x net debt/EBITDA, then TMUS looks attractive to own despite the high P/E premium to CHTR because the market is paying for stronger growth, better profitability, and a much cleaner balance sheet.
TMUS trades at 19.5x P/E versus CHTR at 4.0x, but the operating profile is materially stronger, with TMUS delivering 8.5% revenue growth versus -0.6% for CHTR and a far better ROIC. The modeled implied price of $39.14 suggests a large downside versus TMUS's current $189.10, but that estimate is inconsistent with the provided DCF range of $211.45-$286.08 and the historical band of $170.19-$208.01.
Supporting Metrics